PEPTIDE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHOD OF INHIBITION OF TACHYKININ EFFECT Russian patent published in 1998 - IPC

Abstract RU 2119922 C1

FIELD: chemistry of peptides. SUBSTANCE: products: derivatives of peptides of the formula (I): where R1 is hydrogen, (lower)-alkyl; R2 is (lower)-alkyl, halogen; R3 is hydrogen, (lower)-alkyl, halogen; R4 is (lower)- -alkyl; R5 is aryl, (lower)-alkyl; R6 is NH2 or optionally substituted hydroxyl-group, or their pharmaceutically acceptable salts. Compounds of the formula (I) are synthesized by interaction of compound (II): or its amino-group reactive derivative and compound (III): , or its amino-group reactive derivative. Invention relates to also pharmaceutical composition containing an effective amount of peptide derivative of the formula (I) as an active component or its pharmaceutically acceptable salt, method of inhibition of tachykinin effect by effect on tachykinin receptors - derivative of peptide of the formula (I) at effective amount. The synthesized compounds can be used for treatment of patients with respiratory diseases (asthma, bronchitis, rhinitis and others), ophthalmic diseases, skin diseases (contact dermatitis, diffuse neurodermitis, nettle rash), inflammatory diseases (rheumatic arthritis, osteoarthritis), pains (migraine, headache, tooth, cancer, back pains and others) in humans and animals. Synthesized compounds show antagonism with respect to tachykinin. EFFECT: improved method of synthesis, enhanced effectiveness of compounds synthesized. 6 cl, 4 dwg, 1 tbl, 28 ex

Similar patents RU2119922C1

Title Year Author Number
CYCLOPEPTIDE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT, METHODS OF SYNTHESIS AND PHARMACEUTICAL COMPOSITION 1991
  • Tosiro Ivamoto[Jp]
  • Akikhiko Fudzie[Jp]
  • Kumiko Nitta[Jp]
  • Jasukhisa Tsurumi[Jp]
  • Nobukharu Sigematsu[Jp]
  • Tijosi Kasakhara[Jp]
  • Motokhiro Khino[Jp]
  • Masakuni Okukhara[Jp]
  • Kazuo Sakane[Jp]
  • Kokhdzi Kavabata[Jp]
  • Khidenori Okhki[Jp]
RU2108342C1
PYRAZOLE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS 1993
  • Masaaki Matsuo
  • Kijosi Tsudzi
  • Takasi Ogino
  • Nobukijo Konisi
RU2128172C1
CEPHEM COMPOUNDS AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS 1992
  • Kazuo Sakane[Jp]
  • Kokhdzi Kavabata[Jp]
  • Kenzi Mijaj[Jp]
  • Esikhiko Inamoto[Jp]
RU2081874C1
ETHANOLAMINE DERIVATIVES, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT 1993
  • Juiti Siokava
  • Masanobu Nagano
  • Kijosi Taniguti
  • Kazukhiko Take
  • Takesi Kato
  • Kazunori Tsubaki
RU2125983C1
DERIVATIVES OF N-(3-PIPERIDINYLCARBONYL)-BETA-ALANINE AS ANTAGONISTS OF PLATELET ACTIVATION FACTOR, METHOD OF SYNTHESIS, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT 1994
  • Mitsuru Okhkubo
  • Fumie Takakhasi
  • Tosio Jamanaka
  • Khiroesi Sakai
  • Masajuki Kato
RU2161155C2
HETEROCYCLIC COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND INTERMEDIATE COMPOUNDS 1994
  • Taniguti Kiesi
  • Nagano Masanobu
  • Khattori Kojudzi
  • Tsubaki Kazunori
  • Okitsu Osamu
  • Tabuti Sejitiro
RU2176640C2
POLYPEPTIDE COMPOUND, METHOD OF ITS SYNTHESIS AND PHARMACEUTICAL COMPOSITION 1995
  • Khidenori Oki
  • Masaki Tomisima
  • Akira Jamada
  • Khizasi Takazugi
RU2165423C2
POLYPEPTIDE COMPOUNDS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHOD OF PROPHYLAXIS AND/OR THERAPEUTIC TREATMENT 1994
  • Khidenori Okhki
  • Masaki Tomisima
  • Akira Jamada
  • Khisasi Takasugi
RU2164230C2
METHOD OF SYNTHESIS OF PYRAZOLE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS 1990
  • Matsuo Masaaki[Jp]
  • Tsudzi Kiesi[Jp]
  • Konisi Nobukie[Jp]
  • Nakamura Katsuja[Jp]
RU2021990C1
METHOD OF SYNTHESIS OF ALKANESULFONANILIDE DERIVATIVES OR THEIRS PHARMACEUTICALLY ACCEPTABLE SALTS 1988
  • Masaaki Matsuo[Jp]
  • Kiesi Tsudzi[Jp]
  • Nobukie Konisi[Jp]
  • Khirojuki Okumura[Jp]
RU2012557C1

RU 2 119 922 C1

Authors

Masaaki Matsuo

Dajdzhiro Khagivara

Khirosi Mijake

Dates

1998-10-10Published

1993-04-09Filed